相关实验视频

Updated: Jun 4, 2025

Recombinant α- β- and γ-Synucleins Stimulate Protein Phosphatase 2A Catalytic Subunit Activity in Cell Free Assays

Recombinant α- β- and γ-Synucleins Stimulate Protein Phosphatase 2A Catalytic Subunit Activity in Cell Free Assays

Published on: August 13, 2017

通过合成蛋白质模拟剂和折叠剂抑制酸化α-synuclein聚合

Emily G Oldani^1,2,3, Nicholas H Stillman^1,2, Ryan A Dohoney^1,2

¹Department of Chemistry and Biochemistry, University of Denver, Denver, Colorado 80210, United States.

ACS chemical neuroscience

|December 24, 2024

概括

新的配体有效地抑制了酸化α-Synuclein (αS-129) 的聚合,这是帕金森病等同核蛋白病变中莱维体的关键组成部分. 这些发现为神经退行性疾病提供了新的治疗策略.

科学领域:

神经科学是一个神经科学.
生物化学生物化学
药理学药理学是一个学科.

背景情况:

莱维体 (LB) 是突核蛋白病变的病理标志,包括帕金森病和莱维体痴呆症.
在残留129 (αS-129) 聚合物中酸化α-Synuclein是LB的主要成分,在疾病强化或救援中具有有争议的作用.
抑制αS和αS-129聚合是一种治疗标,但强大的αS-129抑制剂尚未报告.

研究的目的:

评估先前确定的αS聚合对抗剂对αS-129聚合和与αS联合聚合的有效性.
为了确定这些配体是否可以减轻与αS-129和αS凝聚相关的细胞毒性.

主要方法:

利用与帕金森病 (PD) 相关的生物物理和细胞模型.
测试了对αS-129聚合和αS/αS-129联合聚合的寡聚胺和寡基诺林配体.
评估了连接剂在拯救由αS/αS-129凝聚引起的细胞毒性的有效性.

主要成果:

两种测试的配体都显示出对αS-129聚合的强烈对抗作用.
这些配体还有效地抑制了αS和αS-129 (αS/αS-129) 的联合聚合.
通过αS/αS-129凝聚物调解的细胞毒性被连接物显著地挽救.

结论:

这些代表了首次报告的配体,能够强烈抑制Lewy体的主要成分αS-129的聚合.
这些发现为开发针对与聚合相关的同核蛋白病变的新疗法提供了有希望的基础.
奥利戈皮里迪胺和奥利戈基诺林支架显示出向神经退行性疾病中关键病理机制的潜力.

关键词:

莱维的身体.这是一种α-synuclein.基胺酸的含量是多少?橄基诺胺 (Oligoquinolines) 是一种有机胺.酸化的S129 是一种化物.蛋白质模拟器是蛋白质的模拟器.

更多相关视频

Generation of Alpha-Synuclein Preformed Fibrils from Monomers and Use In Vivo

Generation of Alpha-Synuclein Preformed Fibrils from Monomers and Use In Vivo

Published on: June 2, 2019

A Method to Study α-Synuclein Toxicity and Aggregation Using a Humanized Yeast Model

A Method to Study α-Synuclein Toxicity and Aggregation Using a Humanized Yeast Model

Published on: November 25, 2022

相关概念视频

Amyloid Fibrils

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...

Molecular Chaperones and Protein Folding

Molecular Chaperones and Protein Folding

The native conformation of a protein is formed by interactions between the side chains of its constituent amino acids. When the amino acids cannot form these interactions, the protein cannot fold by itself and needs chaperones. Notably, chaperones do not relay any additional information required for the folding of polypeptides; the native conformation of a protein is determined solely by its amino acid sequence. Chaperones catalyze protein folding without being a part of the folded protein.
The...